Fishwild, D M <br/><br/>
Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function.  [electronic resource] 

 -  The Journal of rheumatology  Apr 1994 
 - 596-604 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0315-162X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD<br/>Arthritis, Rheumatoid--blood<br/>B-Lymphocyte Subsets--drug effects<br/>CD5 Antigens<br/>Cytotoxicity, Immunologic--drug effects<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunotoxins--therapeutic use<br/>In Vitro Techniques<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Receptors, IgG--metabolism<br/>Ricin--therapeutic use<br/>T-Lymphocyte Subsets--drug effects